Seven of the Best Index Funds
Get 'em while they're cheap.
Get 'em while they're cheap.
Fund companies are racing to lower index-fund fees thanks to the heated exchange-traded-fund market. Whether you buy ETFs or traditional open-end funds, you are benefiting from this competition. Surprisingly, Fidelity just announced that it is actually raising fees on its Investor share class for Fidelity Spartan International Index to 0.20% from 0.10%. Fidelity had long subsidized fees to keep them that low and had given strong indications that it wouldn't raise the fees, so I'm disappointed.
The good news is that Vanguard is rolling out Admiral shares of Vanguard Developed Markets Index for 0.12%. With that in mind, let's look at some of the cheapest and best open-end index funds.
Vanguard 500 Index Admiral (VFIAX)
For just 0.06% you get exposure to the top of the market. That's quite a bargain for a minimum investment of $10,000. The only knock on it is that total stock market funds have lower turnover and broader exposure. As a result, Vanguard has shifted its emphasis in fund of funds and literature to its total stock market fund. In the past 10 years there has been a huge asset shift between the two. During that time, Vanguard 500 has gained 3.13% annualized and Vanguard Total Stock Market Index (VTSAX) has gained 4.20% annualized. That difference is exaggerated by the fact that small- and mid-cap stocks have beaten large caps, so I wouldn't expect the difference in the next 10 years to be so great.
Vanguard Total Stock Market Index
This fund charges a basis point more, but 0.07% is still very cheap, helping this fund make sense for a passive investor. The bad part about the ETF boom has been all the crazy niche funds that you don't need. This is the kind of broad core fund that serves investors well.
Fidelity Spartan Extended Market Index
The fees are not going up on this fund, and it a good option to round out your domestic holdings if you already own an S&P 500 fund. The fund owns the next 4,500 largest stocks after the top 500. Thus, you cover mid-caps and small caps nicely.
Vanguard Short-Term Bond Index (VBIRX)
With yields on high-quality bonds at pathetically low levels, it makes sense to pinch pennies and buy a fund that charges 0.11%, as this one does. The caveat on bond index funds is that they are nearly all market-weighted, and that means they are dominated by low-yielding government bonds. So this is a decent defensive play, but income is rather meager at just 0.73% for the trailing 30 days.
Vanguard Small Cap Index (VSMAX)
Vanguard significantly improved its small-cap indexing when it switched to the MSCI US Small Cap 1750 from the Russell 2000. The Russell's problems were that it rebalanced infrequently and everyone could see the changes coming and bid up the prices of the names going in. Thus, funds tracking the index were stung. Since the switch, the fund has beaten the category average in 85% of rolling three-year periods.
Vanguard Total Bond Market Index (VBTLX)
This fund charges just 0.11%, and that's a good thing given how low the bond markets' yields are. Low costs and a hefty government-bond weighting have helped of late. So if you have rather modest expectations, this fund should do the job for you.
Vanguard Mid Cap Index (VIMAX)
This fund differs from extended-market indexes in that it just covers mid-caps rather than mid- and small caps. It charges a modest 0.12%.
FundInvestor Newsletter | ||||
Morningstar FundInvestor is a 48-page newsletter dedicated to helping investors pick great mutual funds, build winning portfolios, and monitor their funds for | greater gains. This one-year subscription consists of 12 monthly issues, a Reader's Guide, and four free investing reports. Learn more. | |||
$129.00 for 12 Print Issues | $119.00 for 12 PDF Issues | |||
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.